ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Kabra Drugs Ltd reported revenue from operations of ₹32 Cr (+61.6% YoY) and net profit of ₹1.9 Cr (+5.6% YoY) for Q2 FY27.
Kabra Drugs Ltd reported revenue from operations of ₹46.2 Cr (+541.7% YoY) and net profit of ₹2.1 Cr for Q1 FY27.
Kabra Drugs Ltd reported revenue from operations of ₹35.4 Cr and net profit of ₹1.1 Cr (+175.0% YoY) for Q4 FY26.
Kabra Drugs reported a total income of ₹93.23 Crore and a net profit of ₹4.96 Crore for FY2026. The Board approved these audited results today.
Kabra Drugs Ltd reported net profit of ₹2.6 Cr for Q3 FY26.